Active Ingredient(s): Grepafloxacin
FDA Approved: * November 6, 1997
Pharm Company: * OTSUKA
Category: Antibiotics

Grepafloxacin (trade name Raxar, Glaxo Wellcome) was an oral broad-spectrum fluoroquinolone antibacterial agent used to treat bacterial infections. Grepafloxacin was withdrawn worldwide from markets in 1999,[1][2] due to its side effect of lengthening the QT interval on the electrocardiogram, leading to cardiac events and sudden death.[3] Contents 1 Clinical uses 2 Synthesis 3 Stereochemistry 4 See also 5 References Clinical uses Grepafl... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.